Edgar Hans Bishop

Affiliations

  • at Sana Biotechnology Inc. (SANA), 2025-06-09
  • at Lyell Immunopharma Inc. (LYEL), 2024-06-17
  • Director at Agilent Technologies Inc. (A), 2024-03-19
  • at Celgene Corp (CELG), 2019-11-22
  • Ceo & President at Juno Therapeutics Inc. (JUNO), 2018-03-07
  • Director at Avanir Pharmaceuticals Inc. (AVNR), 2014-02-15
  • Chief Operating Officer at Dendreon Corp (DNDN), 2011-08-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
JUNO $48.56 42,457 $2,061,915.71 2,502,429 2018-01-16 Filing
JUNO $47.69 23,003 $1,097,070.58 2,544,886 2018-01-16 Filing
JUNO $46.52 49,082 $2,283,525.33 2,567,889 2018-01-16 Filing
JUNO $45.53 89,888 $4,092,789.40 2,616,971 2018-01-16 Filing
JUNO $44.72 65,820 $2,943,226.87 2,706,859 2018-01-16 Filing